pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,923 catalysts · 5,627 phase readout · 2,290 8k filing · 240 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 47 catalysts2026-08-06: 13 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 3 catalysts2026-10-28: 2 catalysts2026-10-29: 8 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,627
  • 8k filing2,290
  • earnings240
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT00156767: Adrenal Function in Critical Illness

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Adrenal Insufficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07393867: Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Sponsor: Martin T. King, MD, PhD. Phase: PHASE2. Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07499765: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Acute Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03635567: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Cervical Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05464667: Preoperative Irradiation for Stage I Breast Cancer

Sponsor: Parul Barry. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07646600: Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

Sponsor: AstraZeneca. Phase: . Conditions: Dilated Cardiomyopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT01587300: Neuroblastoma Biology Study

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06004882: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Zika, Influenza

full page →ctgov ↗
›COMPLETEDphase readoutNCT01296724: PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Intensive Care Unit Syndrome

full page →ctgov ↗
›TERMINATEDphase readoutNCT04363580: Creation of Auditory Processing Disorder Screening Tool in French

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Auditory Processing Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04232280: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Sponsor: ModernaTX, Inc.. Phase: PHASE2. Conditions: Cytomegalovirus Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07227896: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

Sponsor: AbbVie. Phase: . Conditions: Parkinson's Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07672496: Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07007546: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

Sponsor: Abbisko Therapeutics Co, Ltd. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06997588: EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: PIK3CA-related Overgrowth Spectrum (PROS)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07197788: Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

Sponsor: Endogenex, Inc.. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07496203: The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

Sponsor: Hacettepe University. Phase: NA. Conditions: Osteo Arthritis of the Knee, Pain, Pain Management, Exercise

full page →ctgov ↗
›COMPLETEDphase readoutNCT07598942: Gingival TrxR1 Expression in Periodontal Health and Periodontitis

Sponsor: Ataturk University. Phase: . Conditions: Periodontitis, Oxidative Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT04631042: Developing Brain, Impulsivity and Compulsivity

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06284642: Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Sponsor: Second Affiliated Hospital of Nanchang University. Phase: PHASE4. Conditions: Aneurysmal Subarachnoid Hemorrhage

full page →ctgov ↗
›RECRUITINGphase readoutNCT05711186: Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Aortic Valve Stenosis, Symptomatic Aortic Stenosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07104383: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Sponsor: Viking Therapeutics, Inc.. Phase: PHASE3. Conditions: Weight Loss

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Endometrial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06156254: Community Care Intervention to Decrease COVID-19 Vaccination Inequities

Sponsor: RAND. Phase: NA. Conditions: COVID-19 Vaccination

full page →ctgov ↗
›RECRUITINGphase readoutNCT06658405: Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

Sponsor: Centre Oscar Lambret. Phase: PHASE2. Conditions: Cervical Lesion

full page →ctgov ↗
›COMPLETEDphase readoutNCT07597694: Verbal Intent and Gaze Cues on Action Prediction in ASD

Sponsor: University of Electronic Science and Technology of China. Phase: . Conditions: Autism Spectrum Disorder (ASD), Intellectual Disability

full page →ctgov ↗
›RECRUITINGphase readoutNCT06747156: A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

Sponsor: Ruijin Hospital. Phase: EARLY_PHASE1. Conditions: Autoimmune Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT04545151: Verapamil SR in Adults With Type 1 Diabetes

Sponsor: Medical University of Graz. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT02192151: Study of PHN131 in Healthy Volunteers

Sponsor: PhytoHealth Corporation. Phase: . Conditions: Analgesia Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06464029: Pathways Mediating Impaired Postural Control in Parkinson's Disease

Sponsor: University of Minnesota. Phase: . Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07601529: Comparison of Anterior Sciatic Nerve Block and Adductor Magnus Muscle Plane Block for Anterior Cruciate Ligament Surgery

Sponsor: Ataturk University. Phase: NA. Conditions: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

full page →ctgov ↗
›RECRUITINGphase readoutNCT06743529: Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Ventilator-Associated Pneumonia (VAP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06737731: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Malignant Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07451431: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Sponsor: Bangladesh Medical University. Phase: PHASE4. Conditions: Diabetic Peripheral Neuropathic Pain (DPNP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06033131: PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

Sponsor: Lina Bergman. Phase: PHASE3. Conditions: Preeclampsia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07222202: Evaluation of Flexible Conductive Hearing Aids

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Conductive Hearing Loss

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07280637: Regenarative Treatment of Periocular Wrinkles With PDRN

Sponsor: University of Taubate. Phase: NA. Conditions: Skin Wrinklings

full page →ctgov ↗
›RECRUITINGphase readoutNCT07145645: Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children

Sponsor: University of Calgary. Phase: PHASE3. Conditions: Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle, Sprain Knee, Strain Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07220772: A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Monogenic Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07146295: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

Sponsor: Isabelle Henskens. Phase: NA. Conditions: Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection, Sentinel Lymph Node, Lymphatic Metastasis, Fluorescence Imaging, Indocyanine Green (ICG), Radioisotopes, Lymph Node Mapping

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07668739: Efficacy of Verciguat in TR and RV Failure

Sponsor: Daejeon St. Mary's hospital. Phase: PHASE4. Conditions: HFrEF, Tricuspid Regurgitation (TR)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07427875: Breathing Exercises for Pain and Anxiety During Arteriovenous Fistula Cannulation

Sponsor: Emine Kaplan Serin. Phase: NA. Conditions: Hemodialysis, Arteriovenous Fistula Cannulation, Breathing Exercises, Pain, Anxiety, Comfort

full page →ctgov ↗
›RECRUITINGphase readoutNCT06066957: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Sponsor: University of Pennsylvania. Phase: PHASE2. Conditions: Cytomegalovirus Infections, Transplant-Related Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07425275: Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Diabetes Mellitus, Diabetic Neuropathies

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07429357: The REWIRE Behaviour Study

Sponsor: Gary Goldfield. Phase: NA. Conditions: Anxiety Depression, Social Media

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02650401: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Solid Tumors, CNS Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07403981: Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

Sponsor: Stanford University. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
← prev
page 123 of 159
next →